Bhaswati Sengupta

Bhaswati Sengupta, Ph.D., has extensive experience in the field of translational medicine and oncology. Currently serving as the Associate Director of Translational Medicine at Cogent Biosciences, Bhaswati has previously held key positions at Pfizer, including Translational Oncology Lead and Clinical Biomarker Assay Lead. Prior to that, Bhaswati was a Senior Scientist at ArcherDX, Inc., specializing in IVD Assay Development, and held a role as Scientist II at Thermo Fisher Scientific within the Research & Development Division. Additionally, Bhaswati has contributed as a Scientific Publication Reviewer for Dove Medical Press. Academic qualifications include a Ph.D. in Biomedical Sciences and a Master's degree in Microbiology and Molecular Biology, both from the University of Central Florida.